Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice

Journal of Experimental Medicine

Volumn 191, Issue 7, 2000, Pages 1247-1252

  Guidotti, Luca G ^a   McClary, Heike ^a   Loudis, Jacquelyn Moorhead ^a   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cytokine; Hepatitis B virus; Liver; Lymphocytic choriomeningitis virus; Nitric oxide

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B; HEPATITIS B VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TRANSGENIC MOUSE; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; INTERFERON INDUCERS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-BETA; LIVER; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POLY I-C; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 0034599831     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.7.1247     Document Type: Article

References (21)

1. Guidotti, L.G., and F.V. Chisari. 1999. Cytokine-induced viral purging - role in viral pathogenesis. Curr. Opin. Microbiol. 2:388-391.
2. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:25-36.
3. McClary, H., R. Koch, F.V. Chisari, and L.G. Guidotti. 2000. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 74:2255-2264.
4. Guidotti, L.G., P. Borrow, M.V. Hobbs, B. Matzke, I. Gresser, M.B. Oldstone, and F.V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Prof. Natl. Acad. Sci. USA. 93:4589-4594.
5. Guidotti, L.G., R. Rochford, L. Chung, M. Shapiro, R. Purcell, and F.V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science. 284:825-829.
6. Kalvakolanu, D.V., and E.C. Borden. 1996. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest. 14:25-53.
7. Lowenstein, C.J., J.L. Dinerman, and S.H. Snyder. 1994. Nitric oxide: a physiologic messenger. Ann. Intern. Med. 120: 227-237.
8. Reiss, C.S., and T. Komatsu. 1998. Does nitric oxide play a critical role in viral infections? J. Virol. 72:4547-4551.
9. Guidotti, L.G., B. Matzke, H. Schaller, and F.V. Chisari. 1995. High level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
10. MacMicking, J.D., C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.-W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:641-650.
11. Shimizu, Y., L.G. Guidotti, P. Fowler, and F.V. Chisari. 1998. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J. Immunol. 161:4520-4529.
12. Ando, K., T. Moriyama, L.G. Guidotti, S. Wirth, R.D. Schreiber, H.J. Schlicht, S. Huang, and F.V. Chisari. 1993. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178: 1541-1554.
13. Campbell, I.L., A. Samimi, and C.S. Chiang. 1994. Expression of the inducible nitric oxide synthase. Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J. Immunol. 153:3622-3629.
14. Kanwar, S., and P. Kubes. 1995. Nitric oxide is an antiadhesive molecule for leukocytes. New Horiz. 3:93-104.
15. Hickey, M.J., K.A. Sharkey, E.G. Sihota, P.H. Reinhardt, J.D. Macmicking, C. Nathan, and P. Kubes. 1997. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11:955-964.
16. Hickey, M.J., and P. Kubes. 1997. Role of nitric oxide in regulation of leucocyte-endothelial cell interactions. Exp. Physiol. 82:339-348.
17. Cavanaugh, V.J., L.G. Guidotti, and F.V. Chisari. 1997. Interleukin-12 inhibits hepatitis B virus replication in HBV transgenic mice. J. Virol. 71:3236-3243.
18. Moskophidis, D., M. Battegay, M.-A. Bruendler, E. Laine, I. Gresser, and R. Zinkernagel. 1994. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and gamma interferon. J. Virol. 68:1951-1955.
19. Muller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264:1918-1921.
20. Leist, T.P., M. Eppler, and R.M. Zinkernagel. 1989. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J. Virol. 63:2813-2819.
21. Wille, A., A. Gessner, H. Lother, and F. Lehmann-Grube. 1989. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic chonomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. Eur. J. Immunol. 19:1283-1288.